Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry
Year: 2026
Type: article
Study design: Observational Study
Authors: N.A. Shamalov, M.Yu. Martynov, E.I. Gusev, N.A. Marskaya, D.R. Khasanova, E.B. Yarovaya, Z.Yu. Chefranova, I.A. Voznuk, A.M. Alasheev, M.V. Sutormin, N.V. Khalo, M.D. Bogatyreva, D.S. Khan, L.L. Korsunskaya, T.V. Kharitonova, K.V. Khoroshavina, L.V. Timchenko, V.N. Nesterova, A.A. Kulesh, N.V. Zhukovskaya, O.V. Androphagina, V.A. Kutsenko, O.E. Ivlev, A.G. Soplenkova, M.K. Guseva, E.A. Karpova, A.M. Semenov, M.P. Semenov, S.V. Ivanov, Yu.A. Romashova, V.V. Beregovykh, S.S. Markin
Institutions: Pirogov Russian National Research Medical University, Federal Center of Brain Research and Neurotechnologies, Kazan State Medical University, Lomonosov Moscow State University, Belgorod National Research University, First Pavlov State Medical University of St. Petersburg, Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky, Research Institute of Emergency Care, Saint-Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine, Tver State Medical University, Nizhny Novgorod Regional Clinical Hospital named after Semashko, Perm State Medical Academy, Samara Regional Clinical Hospital named after V.D. Seredavina, Institute of Biomedical Chemistry, SuperGen (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7128380343